<DOC>
	<DOCNO>NCT00943397</DOCNO>
	<brief_summary>Patients treat either montelukast 4 mg oral granule usual care . Patients complete Protocol MK0476-176-01 ( NCT00943683 ) option enroll study . Additionally , patient asthma 6 11 month age participate Protocol MK0476-176-01 , could also enroll .</brief_summary>
	<brief_title>Extended Safety Study Montelukast Infants Young Children With Chronic Asthma ( 0476-232 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patient successfully complete visit 5 MK0476 Protocol 176 ( NCT00943683 ) OR : Patient good , stable health Patient feed solid food least 1 month Patients least 3 episode asthma asthmalike symptom , occur 8 week age ; least one within 6 month Prestudy Visit Patients need controller therapy accord criterion establish Global Initiative Asthma ( GINA ) guideline Patient hospitalize start study major surgery 4 week prior Patient allergy apple applesauce</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>